Abstract:Background: In recent years, tissue engineered bone by gene-modified stem cells compounded with scaffold materials in repair of bone defect has provided a novel thought for the bone tissue reconstruction. Objective: To explore the effect on repairing mandibular defect with human bone morphogenetic protein-2 (hBMP-2) gene transfected bone marrow mesenchymal stem cells (BMSCs) compounded with coral hydroxyapatite (CHA) scaffolds in osteoporotic rats. Design, time and setting: A randomized control animal experiment was completed at the Key Laboratory for Oral Biomedical Engineering by the State Ministry of Education from June 2005 to October 2006. Materials: Twenty-four unpregnant female Sprague-Dawley rats, 6 months old, SPF gradem weighing 250-300 g, were used to establish models of postmenopausal osteoporosis, The pcDNA3.1-hBMP-2 recombinant plasmid carrying hBMP-2 was offered by the Third Military Medical University of Chinese PLA; CHA scaffolds was offered by the Key Laboratory for Oral Biomedical Engineering by the State Ministry of Education. Methods: Twenty-four SD rats were divided into experimental group and control group at random, each containing 12 animals. Three months later, BMSCs harvested from osteoporotic rats were transfected by pcDNA3.1-hBMP-2 recombinant plasmid, and control group leaved untreated. Three days later, the transfected and untransfected autogenous BMSCs were seeded into CHA scaffolds, respectively. Then the cell/scaffolds composites were implanted into the critical-size defect area in the mandible bone of osteoporotic rats. Main outcome measures: At the 4th and 8th weeks after implantation, immunohistochemical analysis was performed to evaluate the new bone formation, and the amount of newly formed bone was detected semi-quantitatively at the 8th weeks. Results: All 24 SD rats were involved in the result analysis. 1 Newly formed bone was found at the margin of the defect area treated with the BMSCs modified by BMP-2 gene transfer at 4 weeks after implantation. The lamellar bone matrix was visible at 8 weeks. In the control group, only a little bone matrix was observed at the margin of CHA material at 4 weeks after implantation, however, the amount of newly formed bone was much less than the experimental group, and there was some adipose-like tissues at defect margins and central part at 8 weeks after implantation. 2 The percentage of newly formed bone area was (0.046±0.004)% and (0.233±0.015)% in the control group and the experimental group, respectively. There were significant differences in the amount of newly formed bone between two groups (P < 0.01). Conclusion: Tissue engineered bone formed by hBMP-2 gene-modified BMSCs in conjunction with CHA scaffolds, can allow large bone formation for treatment of mandibular defect in osteoporosis rats.

Repairing critical size calvarial defects in rats with the complex of bone marrow mesenchymal stem cells and alginate gel

Enhancing Cranial Defect Repair in Rats: Investigating the Effect of Combining Total Flavonoids from Rhizoma Drynariae with Calcium Phosphate/collagen Scaffolds.

[Experimental Study for Repair of Cranial Defects with Bone Marrow Stromal Cells and Modified Alginate].

Effect of articular chondrocytes combined with sodium alginate hydrogel sphere on rat calvarial defects

Bone regeneration by BMP-2 enhanced adipose stem cells loading on alginate gel

Hybrid scaffolds of Mg alloy mesh reinforced polymer/extracellular matrix composite for critical-sized calvarial defect reconstruction.

Repair of Skull Defects of Rabbit with Cultured Marrow Stem Cells Combined with Alginate

The effects of oyster shell/alpha-calcium sulfate hemihydrate/platelet-rich plasma/bone mesenchymal stem cells bioengineering scaffold on rat critical-sized calvarial defects

Repair of calvarial defects with human umbilical cord blood derived mesenchymal stem cells and demineralized bone matrix in athymic rats

Improved new bone formation capacity of hyaluronic acid-bone substitute compound in rat calvarial critical size defect

Reconstruction of Rat Calvarial Defects with Human Mesenchymal Stem Cells and Osteoblast-Like Cells in Poly-Lactic-co-glycolic Acid Scaffolds

Study on the Chondrogenesis in Vivo of Bone Marrow Stromal Cells Compounded with Alginate Gel

Repairing mandibular defect by gene-modified bone marrow mesenchymal stem cells combined with coral hydroxyapatite scaffold in osteoporotic rats

Repair of calvarial critical-sized defects with BMSCs and Nano-hydoxyapation/collage

Endochondral Ossification Induced by Cell Transplantation of Endothelial Cells and Bone Marrow Stromal Cells with Copolymer Scaffold Using a Rat Calvarial Defect Model

In Vivo Alveolar Bone Regeneration by Bone Marrow Stem Cells/Fibrin Glue Composition

Enhanced Healing of Rat Calvarial Defects with MSCs Loaded on BMP-2 Releasing Chitosan/Alginate/Hydroxyapatite Scaffolds

Restoration of Rat Calvarial Defects by Poly(lactide-Co-glycolide)/hydroxyapatite Scaffolds Loaded with Bone Mesenchymal Stem Cells and DNA Complexes

Compound alginate gelatin and bone marrow mesenchymal stromal cells for the in vivo construction of chondrogenesis secreting type Ⅱ collagen

[A Study on the Chondrogenesis of the Compound of Alginate Gelatin and Bone Marrow Stromal Cells in Vivo].

Reconstruction of Critical Sized Calvarial Defects by Porous Nano-Hydroxyapatite/polyamide 6 Composite with Bone Marrow Mesenchymal Stem Cells in Rat